title: [Betahistine in the treatment of vestibular and coordination disturbances in multiple sclerosis].
abstract: We present the results of the efficacy trial of betahistine (Vestibo) based on the complex clinical/instrumental examination (stabilometric, vestibulometric) in 40 patients with multiple sclerosis of different severity of vestibular and coordination dysfunction. We demonstrated the clinical efficacy and safety of using this drug as one of the areas of symptomatic therapy in treatment vestibular and coordination disturbances in multiple sclerosis.
authors.forename: N F
authors.initials: NF
authors.lastname: Popova
authors.forename: M A
authors.initials: MA
authors.lastname: Chugunova
authors.forename: N L
authors.initials: NL
authors.lastname: Kunel'skaia
authors.forename: A S
authors.initials: AS
authors.lastname: Shagaev
authors.forename: A N
authors.initials: AN
authors.lastname: Boĭko
authors.forename: E I
authors.initials: EI
authors.lastname: Gusev
mesh_terms: D000328:Adult; D001259:Ataxia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001621:Betahistine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D017442:Histamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000503:physiopathology; D012720:Severity of Illness Index; D016896:Treatment Outcome; D015837:Vestibular Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D055815:Young Adult
chemical_list: D017442:Histamine Agonists; D001621:Betahistine